--- title: "家庭医疗的革命：家庭护理测试市场洞察与 2030 年预测" type: "News" locale: "zh-CN" url: "https://longbridge.com/zh-CN/news/225663290.md" description: "全球家庭护理检测市场预计到 2030 年将达到 179.5 亿美元，从 2025 年起年均增长率为 9.36%。这一增长受到可及医疗需求增加、诊断技术进步以及对成本效益解决方案需求的推动。主要发展包括 Cue Health 推出的家庭诊断测试和 Lucira Health 获得 FDA 授权的流感和 COVID-19 检测。老年人群体在市场中占据主导地位，尿液样本和传染病检测占据主要份额。北美由于其医疗基础设施和老龄化人口，拥有最大的市场份额" datetime: "2025-01-21T09:49:06.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/225663290.md) - [en](https://longbridge.com/en/news/225663290.md) - [zh-HK](https://longbridge.com/zh-HK/news/225663290.md) --- # 家庭医疗的革命：家庭护理测试市场洞察与 2030 年预测 Dublin, Jan. 21, 2025 (GLOBE NEWSWIRE) -- The "Home Care Testing Market Size, Share & Trends Analysis Report By Age, By Sample, By Test Type, By Distribution Channel, By Product, By Region, And Segment Forecasts, 2025 - 2030" report has been added to **ResearchAndMarkets.com's** offering. The global home care testing market size is estimated to reach USD 17.95 billion by 2030, registering to grow at a CAGR of 9.36% from 2025 to 2030 . The growth of the market is attributed to factors, such as increasing demand for convenient and accessible healthcare solutions, growing focus on preventative healthcare and wellness, and technological advancements. An increase in technological advancements is another major factor contributing to the market growth. There have been significant advances in diagnostic technologies, such as digital imaging, molecular diagnostics, and lab-on-a-chip systems, which have enabled the development of innovative and effective at-home testing devices. In March 2023, Cue Health, a healthcare technology company, expanded its Cue Care platform with the launch of a suite of at-home diagnostic tests. The tests are designed to provide individuals with quick and accurate results, allowing them to take control of their health and wellness. The new tests include a range of options, such as tests for COVID-19, influenza, and Respiratory Syncytial Virus (RSV). Furthermore, home care testing has helped to reduce healthcare costs. By enabling patients to conduct their own tests at home, healthcare providers can save on the cost of labor and infrastructure needed to perform testing in a healthcare setting. This can help make healthcare more affordable and accessible for patients, particularly those with chronic conditions requiring frequent testing. In addition, home care testing has increased accessibility for patients in rural or remote areas who may not have easy access to healthcare facilities. By enabling patients to conduct tests at home, healthcare providers reach patients who might have difficulty accessing healthcare services.The pandemic has highlighted the importance of regular monitoring and early detection of diseases, which has boosted the demand for home care testing kits. Companies have been developing new technologies and solutions to address the growing demand for quick and accurate testing solutions. This has led to the development of a range of new home care testing products, including rapid antigen tests, antibody tests, and PCR tests, which have all been used to help diagnose and monitor COVID-19. In March 2023, Lucira Health received FDA authorization for its over-the-counter (OTC) flu and COVID-19 test. The test enables individuals to test themselves for COVID-19 and the flu at home, without the need for a healthcare provider. **Home Care Testing Market Report Highlights** - Based on age, the geriatric segment captured the highest market share in 2024 due to the presence of the geriatric population coupled with a high incidence of chronic diseases. - Based on sample, the urine sample segment dominated the market in 2024. Advances in technology have led to more accurate and reliable urine sample testing, allowing for earlier detection and treatment of health conditions. - Based on test type, the infectious disease segment is expected to dominate the market in 2024. The growth of the segment is attributed to factors, such as increasing cases of infectious diseases globally and a high number of product approvals. - Based on distribution channel, the retail pharmacies segment is expected to dominate the market in 2024.These are easily accessible to consumers, with many located in convenient locations, such as shopping centers and grocery stores. - Based on product, the strip segment dominated the market in 2024. The strip tests are relatively inexpensive & easy to use and can be performed at home without the need for specialized equipment. - North America dominated the market and accounted for the largest revenue share of 33.71% in 2024 owing to the presence geriatric population and well-developed healthcare infrastructure. **This report addresses:** - Market intelligence to enable effective decision-making - Market estimates and forecasts from 2018 to 2030 - Growth opportunities and trend analyses - Segment and regional revenue forecasts for market assessment - Competition strategy and market share analysis - Product innovation listing for you to stay ahead of the curve **Report Attribute** **Details** No. of Pages 120 Forecast Period 2024 - 2030 Estimated Market Value (USD) in 2024 $10.52 billion Forecasted Market Value (USD) by 2030 $17.95 billion Compound Annual Growth Rate 9.3% Regions Covered Global **Key Topics Covered:** **Chapter 1. Methodology and Scope** **Chapter 2. Executive Summary **2.1. Market Outlook 2.2. Segment Snapshot 2.3. Competitive Insights Landscape **Chapter 3. Global Home Care Testing Market Variables, Trends & Scope **3.1. Market Lineage Outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.1.1. Growing prevalence of chronic diseases 3.2.1.2. Technological advancements in diagnostic testing 3.2.1.3. Increasing demand for self-monitoring and preventive healthcare 3.2.2. Market Restraint Analysis 3.2.2.1. Lack of reimbursement 3.2.2.2. Limited accuracy and reliability of some tests 3.3. Global Home Testing Market Analysis Tools **Chapter 4. Global Home Care Testing Market: Age Estimates & Trend Analysis **4.1. Segment Dashboard 4.2. Global Home Care Testing Market Age Movement Analysis 4.3. Global Home Care Testing Market Size & Trend Analysis, by Age, 2018 to 2030 (USD Million) 4.4. Pediatric 4.5. Adult 4.6. Geriatric **Chapter 5. Global Home Care Testing Market: Sample Estimates & Trend Analysis **5.1. Segment Dashboard 5.2. Global Home Care Testing Market Sample Movement Analysis 5.3. Global Home Care Testing Market Size & Trend Analysis, by Sample, 2018 to 2030 (USD Million) 5.4. Urine 5.5. Saliva 5.6. Blood 5.7. Others **Chapter 6. Global Home Care Testing Market: Test Type Estimates & Trend Analysis **6.1. Segment Dashboard 6.2. Global Home Care Testing Market Test Type Movement Analysis 6.3. Global Home Care Testing Market Size & Trend Analysis, by Test Type, 2018 to 2030 (USD Million) 6.4. HIV Test Kit 6.5. Diabetes and Glucose Tests 6.6. Cholesterol and Triglycerides Tests 6.7. Pregnancy Tests 6.8. Infectious Diseases Tests 6.9. Urinary Tract Infection Tests 6.10. Others **Chapter 7. Global Home Care Testing Market: Distribution Channel Estimates & Trend Analysis **7.1. Segment Dashboard 7.2. Global Home Care Testing Market Distribution Channel Movement Analysis 7.3. Global Home Care Testing Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million) 7.4. Retail Pharmacies 7.5. Supermarket/Hypermarket 7.6. Online Pharmacies **Chapter 8. Global Home Care Testing Market: Product Estimates & Trend Analysis **8.1. Segment Dashboard 8.2. Global Home Care Testing Market Product Movement Analysis 8.3. Global Home Care Testing Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million) 8.4. Strip 8.5. Cassette 8.6. Panel 8.7. Midstream 8.8. Dip Card 8.9. Others **Chapter 9. Home Care Testing Market: Regional Estimates & Trend Analysis **9.1. Regional Dashboard 9.2. Market Size & Forecasts Trend Analysis, 2018 to 2030: 9.3. North America 9.4. Europe 9.5. Asia Pacific 9.6. Latin America 9.7. MEA **Chapter 10. Competitive Landscape **10.1. Company/Competition Categorization 10.2. Strategy Mapping 10.3. Company Market Position Analysis, 2024 10.4. List of Key Certification Providers/Scheme Owners 10.5. Company Profiles - Abbott - BD - Quidel Corporation - BioSure - F. Hoffmann-La Roche - Nova Biomedical - Siemens Healthcare - ACON Laboratories - OraSure Technologies - Chembio Diagnostics For more information about this report visit https://www.researchandmarkets.com/r/nq5ei4 **About ResearchAndMarkets.com** ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. - Home Care Testing Market ### 相关股票 - [HLTHQ.US](https://longbridge.com/zh-CN/quote/HLTHQ.US.md) - [02030.HK](https://longbridge.com/zh-CN/quote/02030.HK.md) - [301596.CN](https://longbridge.com/zh-CN/quote/301596.CN.md) - [CUE.US](https://longbridge.com/zh-CN/quote/CUE.US.md) - [KEY.US](https://longbridge.com/zh-CN/quote/KEY.US.md) - [09960.HK](https://longbridge.com/zh-CN/quote/09960.HK.md) - [CARE.US](https://longbridge.com/zh-CN/quote/CARE.US.md)